Interestingly, an inverse relationship was noticed between pMEK and pERK levels in response to Binimetinib treatment for both the mutant pancreatic cancer cell lines tested, MiaPaCa and Panc-1 (Figure 7a–d). Here, EIF2AK3 is linked to familial pancreatic carcinoma.